Crowdonomics
All companies
VIRONIX HEALTH INC. logo

VIRONIX HEALTH INC.

Operating

Vironix Health Inc.

Healthcare · Founded 2020

Visit website

AI-enabled early detection and remote monitoring of lung and heart disease

Post-money valuation ⓘ
$12.1M
As of Apr 2023 · from VIRONIX HEALTH INC. Preferred Stock 1 · pre-money + amount raised, not a traded price
Total raised
$907,719
Across 1 round since 2022
Latest share price
$10.66
VIRONIX HEALTH INC. Preferred Stock 1 offering price

Financials

FY2020–FY2024 · from SEC filings · hover any figure for its source
$0
−$25K
2020
2021
$2K
−$141K
2022
$57
−$302K
2023
$2K
−$792K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$0
—
$2,408
$57
$2,325
Cost of goods sold
$0
—
$0
$0
$0
Gross margin
—
—
100%
100%
100%
Net income
-$24,539
—
-$141,223
-$302,311
-$792,139
Taxes paid
$0
—
$0
$0
$1,181
Balance sheet
Cash
$208,912
—
$103,621
$709,378
$842,883
Accounts receivable
$0
—
$0
$0
$0
Total assets
$224,843
—
$234,886
$1,190,951
$1,424,170
Short-term debt
$23,370
—
$10,910
$31,476
$37,841
Long-term debt
$226,000
—
$289,726
$0
$0
Total liabilities
$249,370
—
$300,636
$31,476
$37,841
Other
Headcount
—
3
—
6
6

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Post-money = pre-money + amount raised · caps marked
$12.1M
post-money
VIRONIX HEALTH INC. Preferred Stock 1

A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.

Fundraising history

VIRONIX HEALTH INC. Preferred Stock 1ClosedReg CF · Preferred Equity · via WeFunder
Raised $907.7K / $1.1MInvestors 173Post-money $12.1M

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 2 of 4 annual reports (FY2022–FY2025)

173 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

View all 18 filings on EDGAR
  • Form D/ADec 29, 20250001833036-25-000004
    EDGAR
  • Form D/AAug 8, 20250001833036-25-000002
    EDGAR
  • Form D/ADec 30, 20240001833036-24-000004
    EDGAR
  • Form D/ADec 27, 20240001833036-24-000003
    EDGAR
  • Form DOct 30, 20240001833036-24-000002
    EDGAR
  • Form D/AOct 30, 20240001833036-24-000001
    EDGAR
  • Form C-ARApr 30, 20240001779318-24-000003
    EDGAR
  • Form DMay 31, 20230001833036-23-000005
    EDGAR
Source: ManualCIK 0001833036Share price $10.66

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.